In Brief: Zovirax
This article was originally published in The Tan Sheet
Executive Summary
Zovirax: Warner-Lambert/Glaxo Wellcome 50/50 OTC switch joint venture, under which Warner-Lambert has marketed Glaxo OTC switch products including Zantac 75, will be restructured to include Wellcome products, such as topical Zovirax for cold sores, "which was previously marketed in certain countries under the now-defunct Warner Wellcome joint venture," Warner-Lambert announces July 1...